No matter how cynical the overall market is OmniAb Inc (OABI) performance over the last week is recorded -14.02%

On Tuesday, OmniAb Inc (NASDAQ: OABI) opened lower -4.49% from the last session, before settling in for the closing price of $3.34. Price fluctuations for OABI have ranged from $3.32 to $6.55 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 13.92% annually for the last half of the decade. Company’s average yearly earnings per share was noted -7.60% at the time writing. With a float of $97.86 million, this company’s outstanding shares have now reached $120.22 million.

In an organization with 106 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 21.68%, operating margin of -390.95%, and the pretax margin is -373.44%.

OmniAb Inc (OABI) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of OmniAb Inc is 19.14%, while institutional ownership is 54.34%. The most recent insider transaction that took place on Dec 09 ’24, was worth 33,131. In this transaction Chief Legal Officer of this company sold 8,022 shares at a rate of $4.13, taking the stock ownership to the 323,385 shares. Before that another transaction happened on Dec 09 ’24, when Company’s President and CEO sold 13,634 for $4.13, making the entire transaction worth $56,308. This insider now owns 3,714,447 shares in total.

OmniAb Inc (OABI) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -7.60% per share during the next fiscal year.

OmniAb Inc (NASDAQ: OABI) Trading Performance Indicators

Check out the current performance indicators for OmniAb Inc (OABI). In the past quarter, the stock posted a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.91.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.37 in one year’s time.

Technical Analysis of OmniAb Inc (OABI)

Let’s dig in a bit further. During the last 5-days, its volume was 0.39 million. That was better than the volume of 0.37 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.66%. Additionally, its Average True Range was 0.16.

During the past 100 days, OmniAb Inc’s (OABI) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.73% in the past 14 days, which was lower than the 44.05% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.88, while its 200-day Moving Average is $4.25. However, in the short run, OmniAb Inc’s stock first resistance to watch stands at $3.31. Second resistance stands at $3.42. The third major resistance level sits at $3.48. If the price goes on to break the first support level at $3.13, it is likely to go to the next support level at $3.07. Assuming the price breaks the second support level, the third support level stands at $2.96.

OmniAb Inc (NASDAQ: OABI) Key Stats

There are currently 141,216K shares outstanding in the company with a market cap of 386.03 million. Presently, the company’s annual sales total 34,160 K according to its annual income of -50,620 K. Last quarter, the company’s sales amounted to 4,170 K and its income totaled -16,370 K.